-
Once again, a trendsetter in occupational health, California has created a draft standard on aerosol transmissible diseases that would allow biannual fit-testing of N95-filtering facepiece respirators until at least 2012 but would require the use of powered air purifying respirators (PAPRs) during high-hazard procedures.
-
If you were frustrated by the slow delivery of influenza vaccine last fall, public health officials have a message for you: Get used to it.
-
Boston Scientific (Natick, Massachusetts) reported regulatory approval and market launch in Japan for its Vitality DR implantable cardioverter defibrillator (ICD) system, which it said is the smallest dual-chamber ICD currently offered in Japan.
-
Mayo Clinic (Rochester, New York) reported the development of a new system to speed critical care to acute heart attack patients that dramatically reduces the time that elapses before patients undergo a life-saving procedure - by as much as 45 minutes in some cases.
-
Jack Darby has been named VP worldwide sales and marketing, for AGA Medical (Plymouth, Minnesota).
-
Spectranetics (Colorado Springs, Colorado) last month received the best of all good trial news - halt of a study at three-quarters enrollment, with the FDA determining that its early data from the CELLO trial is sufficient.
-
-
The interventional sector of cardiology faces new challenges and questions concerning DES - and stenting in general - as companies seek to bolster percutaneous therapies and push new devices and technologies into this arena...
-
While Cardiovascular Device Update has been published since 1996, its sister publication, Biomedical Business & Technology and its predecessor newsletter, began publication in 1977, and we retain issues beginning in 1983.
-
Can cardiovascular companies keep growing just by adding new technologies, or do they need to stick only to what they have tended to do the very best? The first quarter of 2007 appeared to indicate that the answer to those questions seems to be: Stay focused.
